Amsterdam (PRWEB UK) 25 October 2014
Split into 3 parts (pharma, medical devices and solution provider views) the report provides a comprehensive look at challenges and priorities for life sciences executives over the coming 12 months - exploring globalization, regulation and areas for competitive advantage. The report also looks at the impact of more future-looking trends such as big data, direct-to-consumer delivery and M&A - a useful benchmarking tool when comparing your operations to competitors and other segments of the life sciences supply chain.
The report also looks at customer-supplier relationships, comparing responses in order to pinpoint differences and synergies between objectives and challenges.
You can see the view and download the report immediately and for free here.
- 58% of pharmaceutical manufacturer respondents carry out direct-to-customer deliveries. The biggest benefit of this? It enables the manufacturer to move closer to the patient
- Only 4% of medical devices SCM executives rate their visibility capabilities as ‘excellent’
- The lack of healthcare-specific capabilities is the main challenge that 3PLs believe their customers face when selecting a 3PL
The issues raised in this report will be discussed at the Life Sciences Supply Chain Summit, taking place in Amsterdam this December 3-4. Senior supply chain executives working at a pharmaceutical or medical devices manufacturer can attend the event with a complimentary pass.
For more information on the event, see the event website http://goo.gl/oJqipy or contact the event organizer, Sarah Reynolds on sreynolds(at)eft(dot)com ; +44 (0)207 375 7243